I'm holding all my IOVA. As you suggest, Lifileucel may (probably?) has applications in other cancers. It certainly looks like a buyout candidate, although that's not a reason to hold the stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.